{"id":970342,"date":"2026-06-03T16:34:12","date_gmt":"2026-06-03T20:34:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/"},"modified":"2026-06-03T16:34:12","modified_gmt":"2026-06-03T20:34:12","slug":"mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/","title":{"rendered":"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting"},"content":{"rendered":"
\n

NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) — MiNK <\/strong><\/a>Therapeutics, <\/strong>Inc.\u00a0(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that its Annual Shareholders Meeting will begin at\u00a09:30 a.m. ET. on\u00a0June 17, 2026, and will be conducted in a virtual format only. Registration for attendees will start at\u00a09:15 a.m. ET.<\/p>\n

To participate in the Annual Shareholders Meeting, shareholders should visit\u00a0www.virtualshareholdermeeting.com\/INKT2026<\/a>\u00a0and enter the 16-digit control number found in their proxy materials. Guests may also access the meeting in listen-only mode. No control number is required for guests.<\/p>\n

\n Webcast Information:<\/strong>\n <\/p>\n

Date:\u00a0Wednesday, June 17, 2026<\/p>\n

Time:\u00a09:30 a.m. ET<\/p>\n

A live webcast and replay will be accessible from the Company’s website at\u00a0https:\/\/investor.minktherapeutics.com\/events-and-presentations<\/a>\u00a0and at\u00a0www.virtualshareholdermeeting.com\/INKT2026<\/a>.<\/p>\n

\n About MiNK Therapeutics<\/strong>\n <\/p>\n

MiNK Therapeutics is a clinical-stage biopharmaceutical company developing off-the-shelf allogeneic iNKT cell therapies for life-threatening conditions driven by immune dysfunction. The company’s lead program, agenT-797, is being evaluated in acute lung injury and critical illness, with a pipeline that extends across immuno-oncology, transplant medicine, and other settings where dysregulated immunity is a driver of morbidity and mortality. MiNK believes that iNKT cell biology, because of its regulatory role across innate and adaptive immunity, may represent a foundational approach to immune restoration applicable across a broad range of conditions. For more information, visit www.minktherapeutics.com<\/a>.<\/p>\n

\n Contacts:<\/strong>\n <\/p>\n

\n Investor Contact<\/strong>
\n
917-362-1370\u00a0
investor@minktherapeutics.com<\/a>\u00a0<\/p>\n

\n Media Contact<\/strong>
\n
781-674-4428
communications@minktherapeutics.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc.\u00a0(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that its Annual Shareholders Meeting will begin at\u00a09:30 a.m. ET. on\u00a0June 17, 2026, and will be conducted in a virtual format only. Registration for attendees will start at\u00a09:15 a.m. ET. To participate in the Annual Shareholders Meeting, shareholders should visit\u00a0www.virtualshareholdermeeting.com\/INKT2026\u00a0and enter the 16-digit control number found in their proxy materials. Guests may also access the meeting in listen-only mode. No control number is required for guests. Webcast Information: Date:\u00a0Wednesday, June 17, 2026 Time:\u00a09:30 a.m. ET A live webcast and replay will be accessible from the Company’s website at\u00a0https:\/\/investor.minktherapeutics.com\/events-and-presentations\u00a0and at\u00a0www.virtualshareholdermeeting.com\/INKT2026. About MiNK Therapeutics … <\/p>\n

Continue reading “MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-970342","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc.\u00a0(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that its Annual Shareholders Meeting will begin at\u00a09:30 a.m. ET. on\u00a0June 17, 2026, and will be conducted in a virtual format only. Registration for attendees will start at\u00a09:15 a.m. ET. To participate in the Annual Shareholders Meeting, shareholders should visit\u00a0www.virtualshareholdermeeting.com\/INKT2026\u00a0and enter the 16-digit control number found in their proxy materials. Guests may also access the meeting in listen-only mode. No control number is required for guests. Webcast Information: Date:\u00a0Wednesday, June 17, 2026 Time:\u00a09:30 a.m. ET A live webcast and replay will be accessible from the Company’s website at\u00a0https:\/\/investor.minktherapeutics.com\/events-and-presentations\u00a0and at\u00a0www.virtualshareholdermeeting.com\/INKT2026. About MiNK Therapeutics … Continue reading "MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-03T20:34:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting\",\"datePublished\":\"2026-06-03T20:34:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/\"},\"wordCount\":253,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/\",\"name\":\"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=\",\"datePublished\":\"2026-06-03T20:34:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/","og_locale":"en_US","og_type":"article","og_title":"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting - Market Newsdesk","og_description":"NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc.\u00a0(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that its Annual Shareholders Meeting will begin at\u00a09:30 a.m. ET. on\u00a0June 17, 2026, and will be conducted in a virtual format only. Registration for attendees will start at\u00a09:15 a.m. ET. To participate in the Annual Shareholders Meeting, shareholders should visit\u00a0www.virtualshareholdermeeting.com\/INKT2026\u00a0and enter the 16-digit control number found in their proxy materials. Guests may also access the meeting in listen-only mode. No control number is required for guests. Webcast Information: Date:\u00a0Wednesday, June 17, 2026 Time:\u00a09:30 a.m. ET A live webcast and replay will be accessible from the Company’s website at\u00a0https:\/\/investor.minktherapeutics.com\/events-and-presentations\u00a0and at\u00a0www.virtualshareholdermeeting.com\/INKT2026. About MiNK Therapeutics … Continue reading \"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-03T20:34:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting","datePublished":"2026-06-03T20:34:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/"},"wordCount":253,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/","name":"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=","datePublished":"2026-06-03T20:34:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTA0MCM3NjM0MTE1IzIyMjMyMTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-therapeutics-announces-its-virtual-2026-annual-shareholders-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=970342"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970342\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=970342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=970342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=970342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}